Provide Feedback |

Press Release/Announcement

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

May 24, 2015

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; November 6, 2008.

This announcement recalls a mislabeled single-use, disposable syringe that could potentially cause dangerous insulin dosing errors.

Available at

Related Resources From the Same Author(s)

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

September 30, 2015

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

March 22, 2010

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

Related Resources

Medication guides: patient medication information. A proposed rule by the Food and Drug Administration.

June 28, 2023

Medication safety issues with newly authorized PAXLOVID.

January 12, 2022

ISMP medication error report analysis.

June 16, 2019

ISMP medication error report analysis.

June 16, 2019

ISMP medication error report analysis.

June 16, 2019

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

The fate of pediatric prescriptions in community pharmacies.

June 3, 2015

E-prescribing: a focused review and new approach to addressing safety in pharmacies and primary care.

December 16, 2013

Make no mistake about it: chain pharmacies are finding innovative ways to combat medication errors.

September 5, 2007

See More About The Topic

Outpatient Pharmacy

Pharmacists

Community Pharmacy

Medication Errors/Preventable Adverse Drug Events

Insulin

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site

Submit Your Training

Continue as a Guest

Continue Logged In

Submit Your Training

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your Toolkit

Continue as a Guest

Continue Logged In

Submit Your Toolkit

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your WebM&M Case

Continue as a Guest

Continue Logged In

Submit Your WebM&M Case

Continue as a Guest

Already have a PSNet

Account?

New Users